Efficacy of dienogest in the treatment of symptomatic adenomyosis: A pilot study

Gynecological Endocrinology

Volumn 30, Issue 10, 2014, Pages 726-729

  Hirata, Tetsuya ^a   Izumi, Gentaro ^a   Takamura, Masashi ^a   Saito, Ako ^a   Nakazawa, Akari ^a   Harada, Miyuki ^a   Hirota, Yasushi ^a   Koga, Kaori ^a   Fujii, Tomoyuki ^a   Osuga, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenomyosis; Dienogest; Pelvic pain

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; DIENOGEST; ESTRADIOL; HEMOGLOBIN; NANDROLONE; PROGESTERONE DERIVATIVE;

ADENOMYOSIS; ADULT; ANEMIA; ARTICLE; BLEEDING; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSMENORRHEA; DYSPAREUNIA; ESTRADIOL BLOOD LEVEL; FATIGUE; FEMALE; GENERAL CONDITION DETERIORATION; GENITAL BLEEDING; HEMOGLOBIN BLOOD LEVEL; HOT FLUSH; HUMAN; METRORRHAGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAINFUL DEFECATION; PELVIC PAIN; PILOT STUDY; RETROSPECTIVE STUDY; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; MIDDLE AGED; TREATMENT OUTCOME;

ADENOMYOSIS; ADULT; FEMALE; HUMANS; METRORRHAGIA; MIDDLE AGED; NANDROLONE; PILOT PROJECTS; PROGESTERONE CONGENERS; TREATMENT OUTCOME;

EID: 84907914186     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.926882     Document Type: Article

References (20)

1. Nelson JR, Corson SL. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report. Fertil Steril 1993;59:441-3.
2. Grow DR, Filer RB. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol 1991;78:538-9.
3. Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis - a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009;91:675-81.
4. Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25:633-41.
5. Momoeda M, Harada T, Terakawa N, et al. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res 2009;35:1069-76.
6. Schindler AE. Dienogest in long-term treatment of endometriosis. Int J Womens Health 2011;3:175-84.
7. Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiol 2005;234:948-53.
8. Togashi K, Nishimura K, Itoh K, et al. Adenomyosis: diagnosis with MR imaging. Radiology 1988;166:111-14.
9. Fedele L, Bianchi S, Dorta M, et al. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril 1992;58:94-7.
10. Tamai K, Togashi K, Ito T, et al. MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics 2005;25:21-40.
11. Kang JL, Wang XX, Nie ML, Huang XH. Efficacy of gonadotropinreleasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Gynecol Obstet Invest 2010;69:73-7.
12. Igarashi M, Abe Y, Fukuda M, et al. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril 2000;74:412-13.
13. Peng FS,Wu MY, Yang JH, et al. Insertion of the Mirena intrauterine system for treatment of adenomyosis-Associated menorrhagia: a novel method. Taiwan J Obstet Gynecol 2010;49:160-4.
14. Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009;79:189-93.
15. Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand 2012;91:489-95.
16. Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2012;285:167-73.
17. Harada M, Osuga Y, Izumi G, et al. Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study. Gynecol Endocrinol 2011;27:717-20.
18. Imaoka I, Ascher SM, Sugimura K, et al. MR imaging of diffuse adenomyosis changes after GnRH analog therapy. J Magn Reson Imaging 2002;15:285-90.
19. Nagata C, Yanagida S, Okamoto A, et al. Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest. J Obstet Gynaecol Res 2012;38:639-44.
20. Kitawaki J, Kusuki I, Yamanaka K, Suganuma I. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-Associated pelvic pain. Eur J Obstet Gynecol Reprod Biol 2011;157:212-16.